Ascentage Pharma to Showcase 17 Clinical Advances at 2026 EHA Congress
Ascentage Pharma will present 17 clinical advances at European Hematology Association Congress in June 2026, featuring data from its key oncology assets.
AAPGclinical trial datachronic lymphocytic leukemia